NCT03512015 (LuCApp) is a NA clinical trial of The Lung Cancer App - LuCApp in Nonsmall Cell Lung Cancer, sponsored by Bocconi University.

Who is sponsoring NCT03512015?

NCT03512015 is sponsored by Bocconi University.

What drugs are being tested in NCT03512015?

Interventions in NCT03512015: The Lung Cancer App - LuCApp, Standard care.

What condition does NCT03512015 study?

NCT03512015 studies Nonsmall Cell Lung Cancer, Small Cell Lung Carcinoma.

Is NCT03512015 still recruiting?

NCT03512015 is currently status unknown. Last updated 30 April 2018.

Last reviewed 2018-04-30 · How we verify

NCT03512015: LuCApp

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Mobile Supportive Care App for Patients With Metastatic Lung Cancer

Status unknown NA Last updated 30 April 2018

What this trial tests

NA trial testing The Lung Cancer App - LuCApp in Nonsmall Cell Lung Cancer in 120 participants. Status unknown.

Timeline

15 May 2018

Primary endpoint
31 December 2019

30 June 2020

Quick facts

Lead sponsor	Bocconi University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	120
Start date	15 May 2018
Primary completion	31 December 2019
Estimated completion	30 June 2020

Drugs / interventions tested

The Lung Cancer App - LuCApp
Standard care — full drug profile →

Conditions studied

Nonsmall Cell Lung Cancer — all drugs for Nonsmall Cell Lung Cancer →
Small Cell Lung Carcinoma — all drugs for Small Cell Lung Carcinoma →

Sponsor

Bocconi University

Who can join

18 and older, any sex, with Nonsmall Cell Lung Cancer or Small Cell Lung Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Self-management interventions can help patients and their families care for themselves along the cancer care continuum. This scenario has witnessed the rapid and ongoing growth in mobile technologies, including mobile health (mHealth). LuCApp (Lung Cancer App) is an application developed by researchers and lung cancer clinicians to gather symptom data in real time and to share it with healthcare professionals. This is a 24-week, two-arm, non-blinded multicenter feasibility parallel randomized controlled trial aimed to evaluate the usability and effectiveness of LuCApp vs standard care to improve self-management of symptoms and health related quality of life in lung cancer patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer.
Ciani O, Cucciniello M, Petracca F, Apolone G, et al · · 2019 · cited 24× · PMID 30772862 · DOI 10.1136/bmjopen-2018-025483
A mobile supportive care app for patients with metastatic lung cancer: the Lung Cancer App (LuCApp) randomized controlled trial.
Pongiglione B, Cucciniello M, Petracca F, Ciani O, et al · · 2025 · cited 1× · PMID 40586961 · DOI 10.1007/s00520-025-09682-5

Verify or expand the search:

Other recruiting trials for Nonsmall Cell Lung Cancer

Currently open trials in the same condition.

NCT04900935 — Patient-centered, Optimal Integration of Survivorship and Palliative Care · NA · recruiting
NCT06147570 — A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer · Phase 2 · recruiting
NCT05358249 — Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation · Phase 1, PHASE2 · active not recruiting
NCT03753685 — X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases · Phase 2 · active not recruiting
NCT03778814 — TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03512015 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bocconi University
Last refreshed: 30 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03512015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing